SEC Info - Acadia Pharmaceuticals Inc.

SEC Info℠

Home

My Interests

Help

Please Sign In

Acadia Pharmaceuticals Inc.
CA
SEC # 1070494

Click to view...

Registrant

About

Filings

Files

Relationships

Names

Topics

Web

*As Of*	*Filing*	*Page*	*Title*	*Docs.*

2/27/24	10-K	1	Business	1
		1	Certain Relationships and Related Transactions, and Director Independence	1
		1	Changes in and Disagreements With Accountants on Accounting and Financial Disclosure	1
4/26/24	DEF 14A	1	Compensation Discussion and Analysis	2
11/2/23	10-Q	1	Condensed Consolidated Balance Sheets	3
		1	Condensed Consolidated Statements of Cash Flows	3
		1	Condensed Consolidated Statements of Comprehensive Loss	3
		1	Condensed Consolidated Statements of Operations	3
		1	Condensed Consolidated Statements of Stockholders' Equity	3
2/27/24	10-K	1	Consolidated Balance Sheets	1
		1	Consolidated Statements of Cash Flows	1
		1	Consolidated Statements of Comprehensive Loss	1
		1	Consolidated Statements of Operations	1
		1	Consolidated Statements of Stockholders' Equity	1
		1	Controls and Procedures	1
11/2/23	10-Q	1	Controls and Procedures	3
2/27/24	10-K	1	Cybersecurity	1
4/26/24	DEF 14A	1	Director Compensation	2
2/27/24	10-K	1	Directors, Executive Officers and Corporate Governance	1
		1	Disclosure Regarding Foreign Jurisdictions that Prevent Inspections	1
		1	Executive Compensation	1
4/26/24	DEF 14A	1	Executive Compensation -- Compensation Discussion and Analysis	2
11/2/23	10-Q	1	Exhibits	3
2/27/24	10-K	1	Exhibits and Financial Statement Schedules	1
11/2/23	10-Q	1	Financial Statements	3
2/27/24	10-K	1	Financial Statements and Supplementary Data	1
		1	Form 10-K Summary	1
4/26/24	DEF 14A	1	Forward-Looking Statements	2
4/28/23	DEF 14A	1	Householding of Proxy Materials	1
		1	Information Regarding the Board of Directors and Corporate Governance	1
2/27/24	10-K	1	Legal Proceedings	1
11/2/23	10-Q	1	Legal Proceedings	3
2/27/24	10-K	1	Management's Discussion and Analysis of Financial Condition and Results of Operations	4
		1	Market for Registrant's Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities	1
		1	Mine Safety Disclosures	1
11/2/23	10-Q	1	Notes to Condensed Consolidated Financial Statements	3
2/27/24	10-K	1	Notes to Consolidated Financial Statements	1
		1	Other Information	2
4/26/24	DEF 14A	1	Other Information for Stockholders	1
		1	Other Matters	2
2/27/24	10-K	1	Part I	1
11/2/23	10-Q	1	Part I. Financial Information	3
2/27/24	10-K	1	Part Ii	1
11/2/23	10-Q	1	Part Ii. Other Information	3
2/27/24	10-K	1	Part Iii	1
		1	Part Iv	1
4/26/24	DEF 14A	1	Pay Versus Performance	2
2/27/24	10-K	1	Power of Attorney (see signature page hereto)	1
		1	Principal Accountant Fees and Services	1
		1	Properties	1
4/26/24	DEF 14A	1	Proposal 1: Election of Directors	2
		1	Proposal 2: Advisory Vote on Executive Compensation	2
4/28/23	DEF 14A	1	Proposal 3: Advisory Vote on Frequency of Solicitation of Stockholder Advisory Votes on Executive Compensation	1
4/26/24	DEF 14A	1	Proposal 3: Approval of the Company's 2024 Equity Incentive Plan	1
		1	Proposal 4: Ratification of Selection of Independent Registered Public Accounting Firm	2
		1	Proxy Statement	2
2/27/24	10-K	1	Quantitative and Qualitative Disclosures About Market Risk	4
4/26/24	DEF 14A	1	Questions and Answers About these Proxy Materials and Voting	2
2/27/24	10-K	1	Report of Independent Registered Public Accounting Firm (PCAOB ID: 42 )	1
		1	Reserved	1
		1	Risk Factors	1
11/2/23	10-Q	1	Risk Factors	3
4/26/24	DEF 14A	1	Security Ownership of Certain Beneficial Owners and Management	2
2/27/24	10-K	1	Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters	1
11/2/23	10-Q	1	Signatures	3
4/26/24	DEF 14A	1	Transactions with Related Persons	2
2/27/24	10-K	1	Unresolved Staff Comments	1

↑Top

Acadia Pharmaceuticals Inc. CA SEC # 1070494

115 Topics within the Past Year Past Two Years Past Three Years Past Four Years Past Five Years Entire Database

Acadia Pharmaceuticals Inc.
CA
SEC # 1070494

115 Topics
within the